Retraction-Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

The Lancet

Volumn 374, Issue 9697, 2009, Pages 1226-

  The Editors of The Lancet, ^a  

^a THE LANCET   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NOTE; PRIORITY JOURNAL; RETRACTED ARTICLE;

EID: 70349771914     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61768-2     Document Type: Note

References (8)

1. Kunz R., Wolbers M., Glass T., and Mann J. The COOPERATE trial: a letter of concern. Lancet 371 (2008) 1575-1656
2. Nakao N., Yoshimura A., Morita H., Takada M., Kayano T., and Ideura T. Combination treatment of angiotensin II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 361 (2003) 117-124
3. Krüger B., Böger C., Stubanus M., Fischereder M., and Krämer B.K. The COOPERATE trial. Lancet 361 (2003) 1054
4. Presne C., Mansour J., Makdassi R., Choukroun G., and Fournier A. The COOPERATE trial. Lancet 361 (2003) 1054
5. Halbekath J., and Schenk S. The COOPERATE trial. Lancet 361 (2003) 1055
6. Vogt L., Laverman G.D., de Zeeuw D., and Navis G. Lancet 361 (2003) 1055-1056
7. Nakao N., Sen H., Kasuga H., Toriyama T., Kawahara H., and Fukagawa M. Effects of combination treatment with losartan and trandolapril on office and ambulatory blood pressures in non-diabetic renal disease: a COOPERATE-ABP substudy. Am J Nephrol 24 (2004) 543-548
8. Bidani A. controversy about COOPERATE ABPM trial data. Am J Nephrol 26 (2006) 629-632